Status:
RECRUITING
Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Postoperative Pain
Anxiety Postoperative
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients who undergo cardiothoracic surgery often experience pain and anxiety around the time of surgery. Currently, treatments for pain and anxiety around the time of surgery include opioids and benz...
Detailed Description
Every year, over 500,000 individuals in the United States undergo cardiothoracic surgery for heart and lung disease. Cardiothoracic surgery can be an extremely traumatic experience for the patient. Th...
Eligibility Criteria
Inclusion
- Be scheduled to undergo any one of the 5 major types of cardiothoracic surgical operations: coronary artery bypass grafting, aortic valve replacement, aortic valve repair, lung resection, and esophagectomy
- Age \> 18
- No cognitive or psychiatric conditions prohibiting study consent or participation.
Exclusion
- Clinical signs of cardiogenic shock at time of surgery
- Severe irreversible hypertension
- Congenital heart disease
- Chronic renal insufficiency defined by Cr ≥ 2.5 or chronic renal replacement therapy
- Evidence of cirrhosis or hepatic synthetic failure
- Patients with odor allergies or anosmia (lost their sense of smell)
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04912531
Start Date
October 1 2022
End Date
June 30 2025
Last Update
November 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114